Recent drug development of dorzagliatin, a new glucokinase activator, with the potential to treat Type 2 diabetes: A review study
Abstract Type 2 diabetes mellitus (T2DM) is a complicated disease related to metabolism that results from resistance to insulin and sustained hyperglycemia. Traditional antidiabetic drugs cannot meet the demand of different diabetes patients for reaching the glycemic targets; thus, the identificatio...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley
2024-06-01
|
| Sarja: | Journal of Diabetes |
| Aiheet: | |
| Linkit: | https://doi.org/10.1111/1753-0407.13563 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|